288 related articles for article (PubMed ID: 31322567)
1. 24S-Hydroxycholesterol Is Associated with Agitation Severity in Patients with Moderate-to-Severe Alzheimer's Disease: Analyses from a Clinical Trial with Nabilone.
Ruthirakuhan M; Herrmann N; Andreazza AC; Verhoeff NPLG; Gallagher D; Black SE; Kiss A; Lanctôt KL
J Alzheimers Dis; 2019; 71(1):21-31. PubMed ID: 31322567
[TBL] [Abstract][Full Text] [Related]
2. Randomized Placebo-Controlled Trial of Nabilone for Agitation in Alzheimer's Disease.
Herrmann N; Ruthirakuhan M; Gallagher D; Verhoeff NPLG; Kiss A; Black SE; Lanctôt KL
Am J Geriatr Psychiatry; 2019 Nov; 27(11):1161-1173. PubMed ID: 31182351
[TBL] [Abstract][Full Text] [Related]
3. Agitation, Oxidative Stress, and Cytokines in Alzheimer Disease: Biomarker Analyses From a Clinical Trial With Nabilone for Agitation.
Ruthirakuhan M; Herrmann N; Andreazza AC; Verhoeff NPLG; Gallagher D; Black SE; Kiss A; Lanctôt KL
J Geriatr Psychiatry Neurol; 2020 Jul; 33(4):175-184. PubMed ID: 31547752
[TBL] [Abstract][Full Text] [Related]
4. Investigating the safety and efficacy of nabilone for the treatment of agitation in patients with moderate-to-severe Alzheimer's disease: Study protocol for a cross-over randomized controlled trial.
Ruthirakuhan MT; Herrmann N; Gallagher D; Andreazza AC; Kiss A; Verhoeff NPLG; Black SE; Lanctôt KL
Contemp Clin Trials Commun; 2019 Sep; 15():100385. PubMed ID: 31338476
[TBL] [Abstract][Full Text] [Related]
5. Longitudinal Course of Agitation and Aggression in Patients with Alzheimer's Disease in a Cohort Study: Methods, Baseline and Longitudinal Results of the A3C Study.
De Mauleon A; Delrieu J; Cantet C; Vellas B; Andrieu S; Rosenberg PB; Lyketsos CG; Soto Martin M
J Prev Alzheimers Dis; 2021; 8(2):199-209. PubMed ID: 33569568
[TBL] [Abstract][Full Text] [Related]
6. Agitation in Alzheimer's disease: Novel outcome measures reflecting the International Psychogeriatric Association (IPA) agitation criteria.
De Mauleon A; Ismail Z; Rosenberg P; Miller D; Cantet C; O'Gorman C; Vellas B; Lyketsos C; Soto M
Alzheimers Dement; 2021 Oct; 17(10):1687-1697. PubMed ID: 34132461
[TBL] [Abstract][Full Text] [Related]
7. Agitation-associated behavioral symptoms in mild cognitive impairment and Alzheimer's dementia.
Van der Mussele S; Le Bastard N; Saerens J; Somers N; Mariën P; Goeman J; De Deyn PP; Engelborghs S
Aging Ment Health; 2015; 19(3):247-57. PubMed ID: 24962058
[TBL] [Abstract][Full Text] [Related]
8. A comparison of the Cohen-Mansfield agitation inventory with the CERAD behavioral rating scale for dementia in community-dwelling persons with Alzheimer's disease.
Weiner MF; Koss E; Patterson M; Jin S; Teri L; Thomas R; Thal LJ; Whitehouse P
J Psychiatr Res; 1998; 32(6):347-51. PubMed ID: 9844950
[TBL] [Abstract][Full Text] [Related]
9. Cholesterol metabolism is associated with soluble amyloid precursor protein production in Alzheimer's disease.
Popp J; Lewczuk P; Kölsch H; Meichsner S; Maier W; Kornhuber J; Jessen F; Lütjohann D
J Neurochem; 2012 Oct; 123(2):310-6. PubMed ID: 22845771
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of memantine for agitation in Alzheimer's dementia: a randomised double-blind placebo controlled trial.
Fox C; Crugel M; Maidment I; Auestad BH; Coulton S; Treloar A; Ballard C; Boustani M; Katona C; Livingston G
PLoS One; 2012; 7(5):e35185. PubMed ID: 22567095
[TBL] [Abstract][Full Text] [Related]
11. Plasma 24S-hydroxycholesterol: a peripheral indicator of neuronal degeneration and potential state marker for Alzheimer's disease.
Papassotiropoulos A; Lütjohann D; Bagli M; Locatelli S; Jessen F; Rao ML; Maier W; Björkhem I; von Bergmann K; Heun R
Neuroreport; 2000 Jun; 11(9):1959-62. PubMed ID: 10884051
[TBL] [Abstract][Full Text] [Related]
12. A randomized placebo-controlled trial of risperidone for the treatment of aggression, agitation, and psychosis of dementia.
Brodaty H; Ames D; Snowdon J; Woodward M; Kirwan J; Clarnette R; Lee E; Lyons B; Grossman F
J Clin Psychiatry; 2003 Feb; 64(2):134-43. PubMed ID: 12633121
[TBL] [Abstract][Full Text] [Related]
13. Change in agitation in Alzheimer's disease in the placebo arm of a nine-week controlled trial.
Rosenberg PB; Drye LT; Porsteinsson AP; Pollock BG; Devanand DP; Frangakis C; Ismail Z; Marano C; Meinert CL; Mintzer JE; Munro CA; Pelton G; Rabins PV; Schneider LS; Shade DM; Weintraub D; Newell J; Yesavage J; Lyketsos CG;
Int Psychogeriatr; 2015 Dec; 27(12):2059-67. PubMed ID: 26305876
[TBL] [Abstract][Full Text] [Related]
14. Assessing patterns of agitation in Alzheimer's disease patients with the Cohen-Mansfield Agitation Inventory. The Alzheimer's Disease Cooperative Study.
Koss E; Weiner M; Ernesto C; Cohen-Mansfield J; Ferris SH; Grundman M; Schafer K; Sano M; Thal LJ; Thomas R; Whitehouse PJ
Alzheimer Dis Assoc Disord; 1997; 11 Suppl 2():S45-50. PubMed ID: 9236952
[TBL] [Abstract][Full Text] [Related]
15. Orphan Nuclear Receptor RORα Regulates Enzymatic Metabolism of Cerebral 24S-Hydroxycholesterol through CYP39A1 Intronic Response Element Activation.
Matsuoka H; Katayama M; Ohishi A; Miya K; Tokunaga R; Kobayashi S; Nishimoto Y; Hirooka K; Shima A; Michihara A
Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32392803
[TBL] [Abstract][Full Text] [Related]
16. Effects on agitation with rivastigmine patch monotherapy and combination therapy with memantine in mild to moderate Alzheimer's disease: a multicenter 24-week prospective randomized open-label study (the Korean EXelon Patch and combination with mEmantine Comparative Trial study).
Yoon SJ; Choi SH; Na HR; Park KW; Kim EJ; Han HJ; Lee JH; Shim YS; Na DL
Geriatr Gerontol Int; 2017 Mar; 17(3):494-499. PubMed ID: 27111084
[TBL] [Abstract][Full Text] [Related]
17. Regulation of Th17/Treg Balance by 27-Hydroxycholesterol and 24S-Hydroxycholesterol Correlates with Learning and Memory Ability in Mice.
Wang T; Cui S; Hao L; Liu W; Wang L; Ju M; Feng W; Xiao R
Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35457188
[TBL] [Abstract][Full Text] [Related]
18. Assessing Alzheimer's disease patients with the Cohen-Mansfield Agitation Inventory: scoring and clinical implications.
Weiner MF; Tractenberg RE; Jin S; Gamst A; Thomas RG; Koss E; Thal LJ
J Psychiatr Res; 2002; 36(1):19-25. PubMed ID: 11755457
[TBL] [Abstract][Full Text] [Related]
19. Is 24(S)-hydroxycholesterol a potent modulator of cholesterol metabolism in Müller cells? An in vitro study about neuron to glia communication in the retina.
Léger-Charnay E; Masson EAY; Morala T; Martine L; Buteau B; Leclere L; Bretillon L; Gambert S
Exp Eye Res; 2019 Dec; 189():107857. PubMed ID: 31654618
[TBL] [Abstract][Full Text] [Related]
20. 24S-hydroxycholesterol: a marker of brain cholesterol metabolism.
Lütjohann D; von Bergmann K
Pharmacopsychiatry; 2003 Sep; 36 Suppl 2():S102-6. PubMed ID: 14574622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
